BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Yokoo T, Ishii T. Histopathologic determinants of regional lymph node metastasis in early colorectal cancer. Cancer. 2008;112:924-933. [PMID: 18181096 DOI: 10.1002/cncr.23248] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Zlobec I, Lugli A. Invasive front of colorectal cancer: Dynamic interface of pro-/anti-tumor factors. World J Gastroenterol 2009; 15(47): 5898-5906 [PMID: 20014453 DOI: 10.3748/wjg.15.5898] [Cited by in CrossRef: 74] [Cited by in F6Publishing: 71] [Article Influence: 6.2] [Reference Citation Analysis]
2 Akishima-fukasawa Y, Ishikawa Y, Akasaka Y, Uzuki M, Inomata N, Yokoo T, Ishii R, Shimokawa R, Mukai K, Kiguchi H, Suzuki K, Fujiwara M, Ogata K, Niino H, Sugiura H, Ichinose A, Kuroda Y, Kuroda D, Ishii T. Histopathological predictors of regional lymph node metastasis at the invasive front in early colorectal cancer: Predictors for LN metastasis in ECC. Histopathology 2011;59:470-81. [DOI: 10.1111/j.1365-2559.2011.03964.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
3 Nunomiya K, Shibata Y, Abe S, Inoue S, Igarashi A, Yamauchi K, Kimura T, Aida Y, Nemoto T, Sato M, Kishi H, Nakano H, Sato K, Kubota I. Relationship between Serum Level of Lymphatic Vessel Endothelial Hyaluronan Receptor-1 and Prognosis in Patients with Lung Cancer. J Cancer 2014;5:242-7. [PMID: 24665348 DOI: 10.7150/jca.8486] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
4 Karamitopoulou E, Lugli A, Panayiotides I, Karakitsos P, Peros G, Rallis G, Patsouris ES, Terracciano L, Zlobec I. Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer. Histopathology. 2010;57:233-243. [PMID: 20716165 DOI: 10.1111/j.1365-2559.2010.03615.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
5 Han J, Hur H, Min BS, Lee KY, Kim NK. Predictive Factors for Lymph Node Metastasis in Submucosal Invasive Colorectal Carcinoma: A New Proposal of Depth of Invasion for Radical Surgery. World J Surg 2018;42:2635-41. [PMID: 29352338 DOI: 10.1007/s00268-018-4482-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
6 Berg KB, Telford JJ, Gentile L, Schaeffer DF. Re-examining the 1-mm margin and submucosal depth of invasion: a review of 216 malignant colorectal polyps. Virchows Arch 2020;476:863-70. [PMID: 31915959 DOI: 10.1007/s00428-019-02711-9] [Reference Citation Analysis]
7 Risio M. The natural history of colorectal adenomas and early cancer. Pathologe. 2012;33 Suppl 2:206-210. [PMID: 22945585 DOI: 10.1007/s00292-012-1640-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kuo E, Wang K, Liu X. A Focused Review on Advances in Risk Stratification of Malignant Polyps.Gastroenterology Res. 2020;13:163-183. [PMID: 33224364 DOI: 10.14740/gr1329] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Karamitopoulou E, Zlobec I, Born D, Kondi-Pafiti A, Lykoudis P, Mellou A, Gennatas K, Gloor B, Lugli A. Tumour budding is a strong and independent prognostic factor in pancreatic cancer. Eur J Cancer. 2013;49:1032-1039. [PMID: 23177090 DOI: 10.1016/j.ejca.2012.10.022] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 9.7] [Reference Citation Analysis]
10 Ichimasa K, Kudo SE, Miyachi H, Kouyama Y, Ishida F, Baba T, Katagiri A, Wakamura K, Hayashi T, Hisayuki T, Kudo T, Misawa M, Mori Y, Matsudaira S, Kimura Y, Kataoka Y. Patient gender as a factor associated with lymph node metastasis in T1 colorectal cancer: A systematic review and meta-analysis. Mol Clin Oncol 2017;6:517-24. [PMID: 28413659 DOI: 10.3892/mco.2017.1172] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kye BH, Jung JH, Kim HJ, Kang SG, Cho HM, Kim JG. Tumor budding as a risk factor of lymph node metastasis in submucosal invasive T1 colorectal carcinoma: a retrospective study. BMC Surg. 2012;12:16. [PMID: 22866826 DOI: 10.1186/1471-2482-12-16] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
12 Loughrey MB, Shepherd NA. Problematic Colorectal Polyps: Is It Cancer and What Do I Need to Do About It? Surg Pathol Clin 2017;10:947-60. [PMID: 29103541 DOI: 10.1016/j.path.2017.07.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Fan H, Zhu JH, Yao XQ. Prognostic significance of B7-H3 expression in patients with colorectal cancer: A meta-analysis. Pak J Med Sci 2016;32:1568-73. [PMID: 28083066 DOI: 10.12669/pjms.326.11511] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
14 Landau MS, Hastings SM, Foxwell TJ, Luketich JD, Nason KS, Davison JM. Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Mod Pathol 2014;27:1578-89. [PMID: 24762549 DOI: 10.1038/modpathol.2014.66] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
15 Liang F, Cao W, Wang Y, Li L, Zhang G, Wang Z. The prognostic value of tumor budding in invasive breast cancer. Pathol Res Pract. 2013;209:269-275. [PMID: 23561623 DOI: 10.1016/j.prp.2013.01.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 6.5] [Reference Citation Analysis]
16 De Rosa M, Rega D, Costabile V, Duraturo F, Niglio A, Izzo P, Pace U, Delrio P. The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care. Therap Adv Gastroenterol 2016;9:861-86. [PMID: 27803741 DOI: 10.1177/1756283X16659790] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
17 Koelzer VH, Zlobec I, Lugli A. Tumor budding in the clinical management of colon and rectal cancer. Colorectal Cancer 2014;3:387-403. [DOI: 10.2217/crc.14.21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
18 Lee SH, Shin SJ, Park DI, Kim SE, Hong SP, Hong SN, Yang DH, Lee BI, Kim YH, Kim HS, Yang SK, Kim HJ, Kim SH, Kim HJ; Multi-Society Task Force for Development of Guidelines for Colorectal Polyp Screening, Surveillance and Management. [Korean guidelines for colonoscopic polypectomy]. Korean J Gastroenterol 2012;59:85-98. [PMID: 22387834 DOI: 10.4166/kjg.2012.59.2.85] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
19 Lugli A, Karamitopoulou E, Panayiotides I, Karakitsos P, Rallis G, Peros G, Iezzi G, Spagnoli G, Bihl M, Terracciano L. CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer. Br J Cancer. 2009;101:1382-1392. [PMID: 19755986 DOI: 10.1038/sj.bjc.6605318] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 6.6] [Reference Citation Analysis]
20 Ueno H, Hase K, Hashiguchi Y, Shimazaki H, Tanaka M, Miyake O, Masaki T, Shimada Y, Kinugasa Y, Mori Y, Kishimoto M, Kameoka S, Sato Y, Matsuda K, Nakadoi K, Shinto E, Nakamura T, Sugihara K. Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters. Am J Surg Pathol 2014;38:197-204. [PMID: 24418853 DOI: 10.1097/PAS.0000000000000113] [Cited by in Crossref: 48] [Cited by in F6Publishing: 27] [Article Influence: 6.9] [Reference Citation Analysis]
21 Hostettler L, Zlobec I, Terracciano L, Lugli A. ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients. World J Gastroenterol 2010; 16(6): 732-739 [PMID: 20135722 DOI: 10.3748/wjg.v16.i6.732] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
22 Zlobec I, Borner M, Lugli A, Inderbitzin D. Role of intra- and peritumoral budding in the interdisciplinary management of rectal cancer patients. Int J Surg Oncol 2012;2012:795945. [PMID: 22900161 DOI: 10.1155/2012/795945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
23 Lee YJ, Huh JW, Shin JK, Park YA, Cho YB, Kim HC, Yun SH, Lee WY. Risk factors for lymph node metastasis in early colon cancer. Int J Colorectal Dis 2020;35:1607-13. [PMID: 32447479 DOI: 10.1007/s00384-020-03618-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Gulluoglu M, Yegen G, Ozluk Y, Keskin M, Dogan S, Gundogdu G, Onder S, Balik E. Tumor Budding Is Independently Predictive for Lymph Node Involvement in Early Gastric Cancer. Int J Surg Pathol. 2015;23:349-358. [PMID: 25911564 DOI: 10.1177/1066896915581200] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
25 Mitrovic B, Schaeffer DF, Riddell RH, Kirsch R. Tumor budding in colorectal carcinoma: time to take notice. Mod Pathol. 2012;25:1315-1325. [PMID: 22790014 DOI: 10.1038/modpathol.2012.94] [Cited by in Crossref: 167] [Cited by in F6Publishing: 161] [Article Influence: 18.6] [Reference Citation Analysis]
26 Karamitopoulou E, Zlobec I, Kölzer V, Kondi-Pafiti A, Patsouris ES, Gennatas K, Lugli A. Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer. Mod Pathol 2013;26:295-301. [PMID: 23018875 DOI: 10.1038/modpathol.2012.155] [Cited by in Crossref: 87] [Cited by in F6Publishing: 92] [Article Influence: 9.7] [Reference Citation Analysis]
27 Puppa G, Senore C, Sheahan K, Vieth M, Lugli A, Zlobec I, Pecori S, Wang LM, Langner C, Mitomi H. Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy. Histopathology. 2012;61:562-575. [PMID: 22765314 DOI: 10.1111/j.1365-2559.2012.04270.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 11.8] [Reference Citation Analysis]
28 Cirillo L, Gotta M, Meraldi P. The Elephant in the Room: The Role of Microtubules in Cancer. In: Gotta M, Meraldi P, editors. Cell Division Machinery and Disease. Cham: Springer International Publishing; 2017. pp. 93-124. [DOI: 10.1007/978-3-319-57127-0_5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
29 段树全, 刘琳, 赵巧燕, 步召德, 李敬, 王卫, 王虎明. TopoⅡ蛋白表达与直肠癌淋巴结转移的关系. 世界华人消化杂志 2014; 22(23): 3521-3526 [DOI: 10.11569/wcjd.v22.i23.3521] [Reference Citation Analysis]
30 Risio M. The Natural History of pT1 Colorectal Cancer. Front Oncol 2012;2:22. [PMID: 22649781 DOI: 10.3389/fonc.2012.00022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
31 Cappellesso R, Luchini C, Veronese N, Lo Mele M, Rosa-Rizzotto E, Guido E, De Lazzari F, Pilati P, Farinati F, Realdon S, Solmi M, Fassan M, Rugge M. Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: a meta-analysis. Hum Pathol. 2017;65:62-70. [PMID: 28438617 DOI: 10.1016/j.humpath.2017.04.013] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 9.5] [Reference Citation Analysis]
32 Morita H, Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Nishimura C, Igarashi Y, Miki K, Ishii T. Histopathological predictor for regional lymph node metastasis in gastric cancer. Virchows Arch. 2009;454:143-151. [PMID: 19104832 DOI: 10.1007/s00428-008-0717-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
33 Beaton C, Twine CP, Williams GL, Radcliffe AG. Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer. Colorectal Dis. 2013;15:788-797. [PMID: 23331927 DOI: 10.1111/codi.12129] [Cited by in Crossref: 110] [Cited by in F6Publishing: 105] [Article Influence: 15.7] [Reference Citation Analysis]
34 Okamura T, Shimada Y, Nogami H, Kameyama H, Kobayashi T, Kosugi S, Wakai T, Ajioka Y. Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer. Dis Colon Rectum 2016;59:396-402. [PMID: 27050601 DOI: 10.1097/DCR.0000000000000567] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
35 Dawson H, Lugli A. Molecular and pathogenetic aspects of tumor budding in colorectal cancer. Front Med (Lausanne). 2015;2:11. [PMID: 25806371 DOI: 10.3389/fmed.2015.00011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
36 Orbán E, Szabó E, Lotz G, Kupcsulik P, Páska C, Schaff Z, Kiss A. Different expression of occludin and ZO-1 in primary and metastatic liver tumors. Pathol Oncol Res 2008;14:299-306. [PMID: 18386163 DOI: 10.1007/s12253-008-9031-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
37 Karamitopoulou E, Wartenberg M, Zlobec I, Cibin S, Worni M, Gloor B, Lugli A. Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system. Histopathology 2018;73:137-46. [PMID: 29495092 DOI: 10.1111/his.13508] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
38 Ervine AJ, Mcbride HA, Kelly PJ, Loughrey MB. Double immunohistochemistry enhances detection of lymphatic and venous invasion in early-stage colorectal cancer. Virchows Arch 2015;467:265-71. [DOI: 10.1007/s00428-015-1792-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
39 Zlobec I. Novel biomarkers for the prediction of metastasis in colorectal cancer. Expert Opin Med Diagn 2013;7:137-46. [PMID: 23530884 DOI: 10.1517/17530059.2013.753054] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
40 Hashmi AA, Hashmi SK, Ali N, Thara K, Ali R, Edhi MM, Faridi N, Khan A. Clinicopathologic features of colorectal carcinoma: features predicting higher T-stage and nodal metastasis. BMC Res Notes 2018;11:52. [PMID: 29351808 DOI: 10.1186/s13104-018-3183-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Glasgow SC, Bleier JI, Burgart LJ, Finne CO, Lowry AC. Meta-analysis of histopathological features of primary colorectal cancers that predict lymph node metastases. J Gastrointest Surg. 2012;16:1019-1028. [PMID: 22258880 DOI: 10.1007/s11605-012-1827-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 6.1] [Reference Citation Analysis]
42 Graham RP, Vierkant RA, Tillmans LS, Wang AH, Laird PW, Weisenberger DJ, Lynch CF, French AJ, Slager SL, Raissian Y. Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort. Am J Surg Pathol. 2015;39:1340-1346. [PMID: 26200097 DOI: 10.1097/pas.0000000000000504] [Cited by in Crossref: 58] [Cited by in F6Publishing: 34] [Article Influence: 9.7] [Reference Citation Analysis]
43 Märkl B, Renk I, Oruzio DV, Jähnig H, Schenkirsch G, Schöler C, Ehret W, Arnholdt HM, Anthuber M, Spatz H. Tumour budding, uPA and PAI-1 are associated with aggressive behaviour in colon cancer. J Surg Oncol. 2010;102:235-241. [PMID: 20740581 DOI: 10.1002/jso.21611] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
44 Bianco F, Arezzo A, Agresta F, Coco C, Faletti R, Krivocapic Z, Rotondano G, Santoro GA, Vettoretto N, De Franciscis S, Belli A, Romano GM; Italian Society of Colorectal Surgery. Practice parameters for early colon cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines. Tech Coloproctol 2015;19:577-85. [PMID: 26403233 DOI: 10.1007/s10151-015-1361-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
45 Märkl B, Arnholdt HM. Prognostic significance of tumor budding in gastrointestinal tumors. Expert Rev Anticancer Ther. 2011;11:1521-1533. [PMID: 21999126 DOI: 10.1586/era.11.156] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
46 王艳红, 李书香, 李增魁, 吴义娟, 赵春倩. 早期大肠癌双镜联合治疗与腹腔镜治疗的疗效比较. 世界华人消化杂志 2016; 24(16): 2592-2596 [DOI: 10.11569/wcjd.v24.i16.2592] [Reference Citation Analysis]
47 Ebbehøj AL, Jørgensen LN, Krarup PM, Smith HG. Histopathological risk factors for lymph node metastases in T1 colorectal cancer: meta-analysis. Br J Surg 2021;108:769-76. [PMID: 34244752 DOI: 10.1093/bjs/znab168] [Reference Citation Analysis]
48 Cheng P, Lu Z, Zhang M, Chen H, Guo Z, Zheng Z, Wang X. Is Additional Surgery Necessary After Non-Curative Endoscopic Submucosal Dissection for Early Colorectal Cancer? J Invest Surg 2021;34:889-94. [PMID: 31809614 DOI: 10.1080/08941939.2019.1697770] [Reference Citation Analysis]
49 Sancho-Muriel J, Pellino G, Cholewa H, Giner F, Bustamante-Balén M, Montesarchio L, García-Granero E, Frasson M. Early colorectal cancer diagnosed after endoscopic resection: Conservative treatment is safe in most of the cases. Proposal for a risk-based management. Cir Esp 2021:S0009-739X(21)00167-6. [PMID: 34120745 DOI: 10.1016/j.ciresp.2021.04.019] [Reference Citation Analysis]
50 Zlobec I, Molinari F, Martin V, Mazzucchelli L, Saletti P, Trezzi R, De Dosso S, Vlajnic T, Frattini M, Lugli A. Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients. World J Gastroenterol 2010; 16(38): 4823-4831 [PMID: 20939111 DOI: 10.3748/wjg.v16.i38.4823] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
51 Ishii M, Ota M, Saito S, Kinugasa Y, Akamoto S, Ito I. Lymphatic vessel invasion detected by monoclonal antibody D2-40 as a predictor of lymph node metastasis in T1 colorectal cancer. Int J Colorectal Dis. 2009;24:1069-1074. [PMID: 19387662 DOI: 10.1007/s00384-009-0699-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
52 García-solano J, Conesa-zamora P, Trujillo-santos J, Mäkinen MJ, Pérez-guillermo M. Tumour budding and other prognostic pathological features at invasive margins in serrated colorectal adenocarcinoma: a comparative study with conventional carcinoma: Histological prognostic factors in SAC. Histopathology 2011;59:1046-56. [DOI: 10.1111/j.1365-2559.2011.04043.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
53 Kai K, Aishima S, Aoki S, Takase Y, Uchihashi K, Masuda M, Nishijima-matsunobu A, Yamamoto M, Ide K, Nakayama A, Yamasaki M, Toda S. Cytokeratin immunohistochemistry improves interobserver variability between unskilled pathologists in the evaluation of tumor budding in T1 colorectal cancer: Interobserver variability in budding. Pathol Int 2016;66:75-82. [DOI: 10.1111/pin.12374] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
54 Mou S, Soetikno R, Shimoda T, Rouse R, Kaltenbach T. Pathologic predictive factors for lymph node metastasis in submucosal invasive (T1) colorectal cancer: a systematic review and meta-analysis. Surg Endosc. 2013;27:2692-2703. [PMID: 23392988 DOI: 10.1007/s00464-013-2835-5] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
55 Kamata I, Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Uzuki M, Fujimoto A, Morita H, Tamai S, Maehara T. Significance of lymphatic invasion and cancer invasion-related proteins on lymph node metastasis in gastric cancer. J Gastroenterol Hepatol. 2009;24:1527-1533. [PMID: 19383080 DOI: 10.1111/j.1440-1746.2009.05810.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
56 Lee SH, Shin SJ, Park DI, Kim SE, Jeon HJ, Kim SH, Hong SP, Hong SN, Yang DH, Lee BI, Kim YH, Kim HS, Kim HJ, Yang SK, Kim HJ; Multi-Society Task Force for Development of Guidelines for Colorectal Polyp Screening, Surveillance and Management. Korean guideline for colonoscopic polypectomy. Clin Endosc 2012;45:11-24. [PMID: 22741130 DOI: 10.5946/ce.2012.45.1.11] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
57 Jepsen RK, Klarskov LL, Lippert MF, Novotny GW, Hansen TP, Christensen IJ, Høgdall E, Riis LB. Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study. Pathology - Research and Practice 2018;214:1273-81. [DOI: 10.1016/j.prp.2018.07.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
58 Macias-Garcia F, Celeiro-Muñoz C, Lesquereux-Martinez L, Gude-Sampedro F, Uribarri-Gonzalez L, Abdulkader I, Alvarez-Castro A, Dominguez-Muñoz JE. A clinical model for predicting lymph node metastasis in submucosal invasive (T1) colorectal cancer. Int J Colorectal Dis 2015;30:761-8. [PMID: 25700808 DOI: 10.1007/s00384-015-2164-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
59 Koelzer VH, Zlobec I, Lugli A. Tumor budding in colorectal cancer--ready for diagnostic practice? Hum Pathol. 2016;47:4-19. [PMID: 26476568 DOI: 10.1016/j.humpath.2015.08.007] [Cited by in Crossref: 113] [Cited by in F6Publishing: 111] [Article Influence: 18.8] [Reference Citation Analysis]
60 Mitrovic B, Handley K, Assarzadegan N, Chang HL, Dawson HAE, Grin A, Hutchins GGA, Magill L, Quirke P, Riddell RH, Gray RG, Kirsch R; QUASAR Collaborative Group. Prognostic and Predictive Value of Tumor Budding in Colorectal Cancer. Clin Colorectal Cancer 2021;20:256-64. [PMID: 34099382 DOI: 10.1016/j.clcc.2021.05.003] [Reference Citation Analysis]
61 Ueno H, Hase K, Hashiguchi Y, Shimazaki H, Yoshii S, Kudo SE, Tanaka M, Akagi Y, Suto T, Nagata S, Matsuda K, Komori K, Yoshimatsu K, Tomita Y, Yokoyama S, Shinto E, Nakamura T, Sugihara K. Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review. J Gastroenterol. 2014;49:1314-1323. [PMID: 24065123 DOI: 10.1007/s00535-013-0881-3] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]